Assessing the accuracy of [¹⁸F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients.

"Declarations Ethics approval and consent to participateThe study was approved by the Regional Ethics. Committee in Lund (nr 2016/417, 2018/753) and all patients signed a written informed consent. All methods were carried out in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Consent for publicationWritten informed consent was obtained from the patient for publication of this case report and accompanying images. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding Open access funding provided by Lund University. This work was supported by grants from The Swedish Cancer Society (#CAN 2018/522), The Research Funds at Skåne University Hospital, The Governmental Funding (ALF) through The Faculty of Medicine, Lund University (contract numbeF2018:810) and The Swedish Prostate Cancer Federation."